Vaxart Inc (NASDAQ: VXRT): Reassessing Prospects

Vaxart Inc (VXRT) concluded trading on Wednesday at a closing price of $1.41, with 5.36 million shares of worth about $7.56 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 78.50% during that period and on Wednesday the price saw a gain of about 14.63%. Currently the company’s common shares owned by public are about 168.84M shares, out of which, 167.57M shares are available for trading.

According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 23 times over the past 12 months. They bought 1,291,074 shares in 23 of the transactions. In 0 selling transactions, insiders dumped 0 shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stock saw a price change of 18.49% in past 5 days and over the past one month there was a price change of 83.12%. Year-to-date (YTD), VXRT shares are showing a performance of 146.16% which increased to 42.35% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.53 but also hit the highest price of $1.59 during that period. The average intraday trading volume for Vaxart Inc shares is 1.53 million. The stock is currently trading 28.83% above its 20-day simple moving average (SMA20), while that difference is up 71.88% for SMA50 and it goes to 71.84% higher than SMA200.

Vaxart Inc (NASDAQ: VXRT) currently have 168.84M outstanding shares and institutions hold larger chunk of about 18.55% of that.

The stock has a current market capitalization of $238.06M and its 3Y-monthly beta is at 0.46. It has posted earnings per share of -$0.64 in the same period. It has Quick Ratio of 5.07 while making debt-to-equity ratio of 0.37. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VXRT, volatility over the week remained 7.88% while standing at 9.83% over the month.

Analysts are in expectations that Vaxart Inc (VXRT) stock would likely to be making an EPS of -$0.14 in the current quarter, while forecast for next quarter EPS is $0 and it is -$0.49 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.16 which is -$0.13 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.18 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 29.37% while it is estimated to increase by 21.35% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on December 29, 2021 offering a Buy rating for the stock and assigned a target price range of between $13 and $12 to it. Coverage by Cantor Fitzgerald stated Vaxart Inc (VXRT) stock as an Overweight in their note to investors on November 02, 2021, suggesting a price target of $15 for the stock. On June 29, 2021, B. Riley Securities Downgrade their recommendations, while on June 24, 2021, Jefferies Initiated their ratings for the stock with a price target of $13. Stock get an Overweight rating from Piper Sandler on June 11, 2021.

Most Popular

Related Posts